John C. Jacobs
John C. Jacobs is the president and CEO of Novavax, a biotechnology company known for developing vaccines, including a protein-based COVID-19 vaccine. He was recently in the news for announcing plans to provide access to Novavax's updated COVID-19 vaccine for eligible individuals this fall.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United States | 1 | 6.00 | 0.04% | +0% | 331,002,651 | 127,751 | $21,000,000 | 8,105$ |
| Totals | 1 | 331,002,651 | 127,751 | $21,000,000 | 8,105$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
John C. Jacobs, president and CEO of vaccine maker Novavax, said in that company’s news release.
6